αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/TBPH

TBPH

TBPH — Institutional Holders Breakdown

Theravance Biopharma, Inc.

-$16.8M

Net Activity

Data as of: 2026-03-31

Institutions Holding

174

Popularity Rank

#3228

Avg Weight

0.15%

Total Value

$819.5M

Ownership Trend

174 institutions currently hold TBPH, with 95 net buyers and 82 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

82

Net Buying Institutions

95

Key Holders

Key Holders

Top 5 by Value

MA
Madison Avenue Partners, LP
$154.4M
WA
Weiss Asset Management LP
$121.0M
NM
Newtyn Management, LLC
$78.6M
BI
BlackRock, Inc.
$69.7M
IC
Irenic Capital Management LP
$44.8M

Top 5 by Conviction

NM
Newtyn Management, LLC
8.40%
MA
Madison Avenue Partners, LP
6.71%
IC
Irenic Capital Management LP
2.92%
WA
Weiss Asset Management LP
2.05%
RC
Rangeley Capital, LLC
1.62%
View all 174 holding institutions

Across its top 20 institutional holders, TBPH's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 11/100, avg. turnover score 45/100).

Quarterly Activity

Recent Activity

+$491.6M

Total Buy Value

$199.5M

Total Sell Value

New buy35
Trim48
Add60
Sold out34

95

Net Buyers

82

Net Sellers

Smart Money Convergence

TBPH does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/TBPH

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$218K

Total Est. Value

13K shares

Planned Shares

Last Filed 2026-06-15
FilerTitle/RelationshipFiling DatePlanned SharesEst. Value
Farnum RhondaOfficer2026-06-1513K shares$218K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

G8807B106, 88338T104

FAQ

Who are the top institutional investors holding Theravance Biopharma, Inc. (TBPH)?
Major stakeholders currently include Madison Avenue Partners, LP ($154.4M), Weiss Asset Management LP ($121.0M), Newtyn Management, LLC ($78.6M). Based on the latest 13F filings, there are a total of 174 tracked investment funds and institutions maintaining positions in TBPH.
What is the overall institutional sentiment toward TBPH recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $16.8M, driven by 95 managers accumulating shares while 82 reduced their exposure.
Which institutions have been selling or reducing their TBPH positions?
In the latest period, 48 funds trimmed their holdings, and 34 managers completely exited their positions. The aggregate reported sell value was $199.5M.
Are there any notable investors adding TBPH to their portfolios?
Yes, buying activity remains notable. 35 institutions opened new positions in {ticker}, and 60 existing holders added to their shares. The total reported buy value for the quarter amounted to $491.6M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access TBPH's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/TBPH

CLI

npx alphasmo stocks get TBPH
Full API & MCP documentation →